Welcome to our investor pages

Medical technology company Optomed is leading producer of handheld fundus cameras globally.

  • Net sales 13,0 EUR, million
  • Gross margin 68.8  %
  • Adjusted EBITDA -0.7 EUR, million
  • Equity ratio 64.6 %
Key figures

Share Price
Nasdaq Helsinki Stock Exchange

Optomed Plc’s interim report Q1 2021

Read more

Latest releases

Next IR events

Jun 2 - Jun 2, 2021

Red Eye Growth Day

Aug 5 - Aug 5, 2021

Optomed will publish H1 2021 Financial Report

Sep 13 - Sep 13, 2021

Kepler Cheuvreux Autumn Conference 2021

Sep 28 - Sep 28, 2021

Redeye Medtech & Diagnostics

Nov 4 - Nov 4, 2021

Optomed will publish Q3-2021 Interim Report

Nov 11 - Nov 11, 2021

Redeye Life Science Day

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Read more